Demant Shares Surge 4% on KIND Acquisition; Ethereum Jumps 10.10%

Total 450 words · 2 mins read

Key Takeaways

  • Demant shares jumped 4% after DKr5.2 billion deal to acquire German retailer KIND.
  • Ethereum up 10.10%, trading at $2,771.67 on June 10, 2025.
  • Peter Thiel-backed Bullish files for US IPO amid crypto market resurgence.
  • UBS shares slid 7% on capital rule concerns on June 10, 2025.
  • Tilray shareholders approve reverse stock split on June 10, 2025.

Top Stories

Demant shares jump 4% after KIND deal

On 2025-06-11, Demant shares surged 4% following a DKr5.2 billion deal to acquire German retailer KIND. Navamya Acharya reported the news at 06:09 AM.

Ethereum up 10.10%, trading at $2,771.67

On June 10, 2025, the Investing.com Index reported that Ethereum was trading at $2,771.67 at 09:04 (13:04 GMT), marking a 10.10% increase for the day.

Peter Thiel-backed Bullish files for US IPO

On 2025-06-10, FT reported that Bullish, a company backed by Peter Thiel, has filed for a US IPO. This comes amid a resurgence in the crypto market.

UBS shares slid 7% on capital rule concerns

On 2025-06-10, UBS shares experienced a 7% decline. Analysts cited Swiss capital rules potentially hindering buybacks as the reason for the stock drop.

Tilray shareholders approve reverse stock split

On June 10, 2025, Tilray shareholders voted in favor of a proposal for a reverse stock split.

Economic Pulse

Japan's wholesale inflation slows, BOJ pressure eases

On June 10, 2025, Japan's wholesale inflation slowed down. This development is expected to alleviate pressure on the Bank of Japan (BOJ).

Market Snapshot

Mexico stocks close higher, S&P/BMV IPC up 0.49%

deVere Group anticipates a turbulent summer market

On 2025-06-10, deVere Group's CEO issued a report anticipating a turbulent summer market.

Stock Insights

EOS climbs 11% on investor confidence

On June 10, 2025, EOS experienced an 11% increase in value as investors showed growing confidence.

UroGen Pharma faces securities class action

On 2025-06-10, Hagens Berman reported that UroGen Pharma Ltd. (URGN) is facing a securities class action. This is due to the FDA’s briefing document and the ODAC vote against UGN-102.

Scotiabank sees BAM selloff as buying opportunity

On 2025-06-10, Scotiabank viewed the BAM selloff as a 'tactical buying opportunity'.

Judge rejects class action in Google privacy lawsuit

On 2025-06-10, a judge rejected a class action lawsuit related to Google's privacy practices.

Digital 9 Infrastructure completes SeaEdge UK1 sale

On 2025-06-11, Digital 9 Infrastructure finalized the sale of SeaEdge UK1 and used the proceeds to repay its debt.

RBC Capital maintains ratings for Alkermes, Gilead

On June 10, 2025, RBC Capital maintained its stock ratings for both Alkermes and Gilead Sciences. Safety concerns were acknowledged for Alkermes, while access hurdles were noted for Gilead Sciences.

MacroGenics discusses pipeline expansion at Goldman Sachs

On 2025-06-10, Investing.com published a transcript of MacroGenics' presentation at the Goldman Sachs Conference. The discussion centered on the company's strategic pipeline expansion.

Global Expansion

BBVA to expand in Abu Dhabi with branch

On 2025-06-10, it was reported that BBVA is planning to expand its presence in Abu Dhabi by opening a new branch.

Follow What Matters to You

What interests you today?

Initializing Request

Extracting Keywords

Analyzing Relevant Sources

Generating Your Channel

Suggested Topics